Finance
Results: 27673-27684 of 35675

Options Technology Achieves Microsoft Cloud Security Specialization, Solidifying Commitment to Excellence in Security Solutions

Sangamo Therapeutics Announces Data From Novel Proprietary Neurotropic AAV Capsid Demonstrating Industry-leading Blood-brain Barrier Penetration and Brain Transduction in NHPs

As phase I of 511MW project is connected to grid, TrinaTracker's Vanguard 1P makes Uzbekistan greener

Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia






